RxDoctor Payments Data

Carmen Bruno, DPM

Podiatrist · Marrero, LANPI 1932595345

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,404 of the $3,350 with a category attached, or 71.8%. 13 manufacturers reported payments, led by Stryker at 42.3% of the total. Reporting peaked in 2019 at $1,146 and has fallen 59.7% since, to $462 in 2025.

$3,350in general payments, 2019–2025

Across 40 payments — averaging $83.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1K
  • Biotissue Holdings Inc.$623
  • Mimedx Group, Inc.$400
  • Sanara Medtech Inc.$167
  • Integra Lifesciences Corporation$154
  • Organogenesis Inc.$136
  • plus $451 from 7 others

What the payments were for

  • Travel & lodging$94628%
  • Food & beverage$2,40472%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,350 in reported general payments places this provider in the 60th percentile of 68 podiatrist providers in Louisiana.

See all podiatrist providers in Louisiana

Medicare billing

Part B allowed, 2024
$29,475
Medicare patients
249
Services billed
472

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox431$10,182
Diclofenac Sodium162$4,396
Ketoconazole126$3,016
Ammonium Lactate179$2,629
Lidocaine19$1,495
Doxycycline Hyclate86$808
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav50$565
Tobramycin70$468
Acetaminophen-CodeineAcetaminophen With Codeine33$247
Methylprednisolone31$225
Meloxicam63$105

Paid to pharmacies, not to this prescriber.

Other podiatrist in Marrero

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →